Kraig Biocraft Laboratories (KBLB) FCF Margin (2016 - 2018)

Kraig Biocraft Laboratories has disclosed FCF Margin across 3 years of filings, most recently posting 22.8% for Q3 2018.

• FCF Margin for Q3 2018 came in at 22.8%, up 54417.0% year-over-year; the trailing twelve-month figure through Jun 2019 was 393.01% (down 28432.0% YoY), and the FY2021 annual result was 4744907.5%, changed N/A from the prior year.
• FCF Margin came in at 22.8% for Q3 2018 at Kraig Biocraft Laboratories, up from 42.1% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 22.8% in Q3 2018 to a low of 1418.66% in Q4 2016.
• The 3-year median for FCF Margin is 123.07% (2017), against an average of 490.72%.
• Across the five-year window, FCF Margin soared 129558 bps in 2017 and soared 54417 bps in 2018, its largest moves.
• Kraig Biocraft Laboratories' FCF Margin stood at 1418.66% in 2016, then jumped by 91 bps to 123.07% in 2017, then jumped by 81 bps to 22.8% in 2018.
• The last three FCF Margin figures came in at 22.8% (Q3 2018), 42.1% (Q2 2018), and 77.9% (Q1 2018), per Business Quant data.